
Balchem Corporation
NASDAQ•BCPC
CEO: Mr. Theodore L. Harris
Sector: Basic Materials
Industry: Chemicals - Specialty
Listing Date: 1986-06-03
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
Contact Information
Market Cap
$4.99B
P/E (TTM)
33.7
vs Industry 31.1
Dividend Yield (TTM)
0.6%
52W High
$185.96
52W Low
$139.17
52W Range
6.2
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Strong • 6.2 / 9 points
Scoring Range (0-9) 
 8-9: Excellent Value
 6-7: Strong Fundamentals
 4-5: Average Quality
 0-3: Weak Performance
Data Period: 2015-2024
Financial Dashboard
Q3 2025 Data
Revenue
$267.56M+11.51% 
4-Quarter Trend
EPS
$1.25+20.19% 
4-Quarter Trend
FCF
$50.67M+20.20% 
4-Quarter Trend
Earnings Highlights
Key Highlights
No Data Available
Risk Factors
No Data Available
Outlook
No Data Available
Peer Comparison
Revenue (TTM)
 SSL
SSL$29.13B
$9.94B
 AXTA
AXTA$5.17B
Gross Margin (Latest Quarter)
63.1%
53.3%
 ESI
ESI42.2%
Key Metrics
| Symbol | Market Cap | P/E (TTM) | ROE (TTM) | Debt to Assets | 
|---|---|---|---|---|
| ESI | $6.28B | 26.2 | 9.4% | 32.2% | 
| AXTA | $6.21B | 13.5 | 21.3% | 0.3% | 
| BCPC | $4.99B | 33.7 | 12.1% | 11.4% | 
Long-Term Trends
Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4-Quarter Revenue CAGR
+3.7%
Moderate Growth
4-Quarter Net Income CAGR
+6.3%
Gradual Improvement in Profitability
Cash Flow Stability
100%
Strong Cash Flow Performance
Research & Insights
Reports
All Years
- Form 10-Q - Q2 2025Period End: Jun 30, 2025|Filed: Jul 31, 2025|Revenue: $255.47M+9.1%|EPS: $1.18+19.2%Beat
- Form 10-Q - Q1 2025Period End: Mar 31, 2025|Filed: Apr 24, 2025|Revenue: $250.52M+4.5%|EPS: $1.14+26.7%Beat
- Form 10-K - FY 2024Period End: Dec 31, 2024|Filed: Feb 21, 2025|Revenue: $953.68M+3.4%|EPS: $3.97+17.5%Meet
- Form 10-Q - Q3 2024Period End: Sep 30, 2024|Filed: Oct 25, 2024|Revenue: $239.94M+4.3%|EPS: $1.04+14.3%Miss
- Form 10-Q - Q2 2024Period End: Jun 30, 2024|Filed: Jul 26, 2024|Revenue: $234.08M+1.2%|EPS: $0.99+5.3%Miss
- Form 10-Q - Q1 2024Period End: Mar 31, 2024|Filed: May 3, 2024|Revenue: $239.66M+3.1%|EPS: $0.90+26.8%Miss
- Form 10-K - FY 2023Period End: Dec 31, 2023|Filed: Feb 16, 2024|Revenue: $922.44M-2.1%|EPS: $3.38+2.7%Miss
- Form 10-Q - Q3 2023Period End: Sep 30, 2023|Filed: Oct 27, 2023|Revenue: $229.95M-5.9%|EPS: $0.91+15.2%Miss